Further to DrugAlert volume 917, HPS Pharmacies wishes to provide an update on the availability of morphine oral solution. While Ordine® Oral Solution was discontinued by Mundipharma in 2023, Arrotex Pharmaceuticals has taken over sponsorship of the Ordine® range and anticipates a return to normal supply later this year.

The table below details the expected return dates for each strength of morphine oral liquid (currently branded as Ordine®, but may be rebranded).

Morphine Oral Liquid Strength Estimated return date Overseas alternative (S19A)
1 mg/mL 27 September 2024 Yes
2 mg/mL 23 August 2024 Yes (also PBS listed)
5 mg/mL 27 September 2024 Yes – available mid-July 2024
10 mg/mL 29 November 2024 Yes – available mid-July 2024 (also PBS listed)

Information to note when considering one of the S19A alternatives includes:

  • Morphine sulfate 10mg/5mL oral solution (Martindale Pharma)
    • Warning – this product contains ethanol (0.4mL per 5mL) and sucrose (2.25g per 5mL).
  • Morphini HCl Streuli (morphine hydrochloride) 10mg/mL oral drops (Switzerland)
    • Warning – this product is not labelled in English. Additional care is required when storing and dispensing this medicine. Appropriate auxiliary labels should be provided. Health professionals should refer to the Australian product information for dosing information.
    • Warning – this product contains alcohol (1.2% v/v).

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Arrotex on 1800 195 055 or your pharmacist at HPS Pharmacies.


Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates